Should you buy Sabre Corpo stock now?
Yes, the technical signal for Sabre Corpo is currently BUY. Sabre Corpo trades at $2.20 as of 8/6/2026. The overall technical signal is: Strong Buy. The technical analysis shows the following: MACD is positive (bullish trend) at 0.044 with rising momentum (signal: 0.004); RSI is at 65.1 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $1.99 is 9.5% below the current price. The stock is in a broader uptrend (above SMA50/SMA200). This is a technical observation based on current data, not investment advice.
What is the price target for Sabre Corpo stock?
The average analyst price target for Sabre Corpo is $1.99. The current price is $2.20, which gives a downside of 9.5%. Based on this, the stock is considered fairly valued. The fair value range (±10% of the price target) is between $1.79 and $2.19.
Is Sabre Corpo a dividend stock?
No, Sabre Corpo does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Sabre Corpo stock?
Sabre Corpo is rated as a stock with extreme risk. the annual standard deviation is 93.8%, which classifies the stock as extreme risk.
Is Sabre Corpo overvalued?
Sabre Corpo is considered fairly valued – the price is close to the analyst price target. Sabre Corpo has the following valuation ratios: a P/S ratio of 0.3, a P/B ratio of 145.1. The stock trades close to the analyst price target and is considered fairly valued.
Is Sabre Corpo overbought?
No, Sabre Corpo is not overbought. RSI is at 65.1 (neutral zone). The technical indicators show: RSI is at 65.1 (upper neutral zone), which shows positive momentum but is not yet overbought. In addition, the price is 20.9% above the 20-day average (short-term uptrend). In addition, MACD is positive with rising momentum (bullish).
When is the next Sabre Corpo earnings report?
Sabre Corpo reports earnings TODAY, August 6, 2026! The stock currently trades at $2.20. Watch how the price reacts after the release. The RSI is at 65.1, so the report can reinforce the current technical trend.
Is Sabre Corpo shorted?
Yes, Sabre Corpo is shorted with 11.0% of the free float sold short. This is a very high level of short selling, which points to considerable bearish sentiment. A positive earnings report or unexpectedly good news can trigger a short squeeze with sharp price gains. Data is updated daily based on official filings with the SEC.
Are insiders buying Sabre Corpo stock?
No, insiders are not buying Sabre Corpo shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 1 sales. On a net basis, 13,003 $ worth of shares were sold. Across the last 20 reported transactions, the split is 15 purchases and 5 sales, with a net 14,887,304 $ bought. Active sellers include Kindle Jami, CATTO JENNIFER, BOAS ROCHELLE and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Sabre Corpo a good stock?
Based on our total score, Sabre Corpo is rated as a good stock with a total score of 68 out of 100. The stock scores above average on value, quality and momentum – it is among the top 32% in our database. The score is made up of Value: 59/100, Quality: 60/100, Momentum: 86/100. In addition: technical signal: Strong Buy. Whether Sabre Corpo is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Sabre Corpo stock?
The outlook for Sabre Corpo based on current data: the average analyst price target is $1.99 (-9.5%); the stock is in an uptrend (above SMA50 and SMA200); the next earnings report is due on 8/6/2026, which can move the price. Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Sabre Corpo stock rising?
Sabre Corpo is rising right now. The technical indicators show: the price is 20.9% above the 20-day average; MACD is positive with rising momentum (bullish signal); short interest is 11.0% (high – many are betting on a decline); insiders have mostly been buying the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Sabre Corpo go?
The average analyst price target for Sabre Corpo is $1.99, which is 9.5% below the current price of $2.20. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Sabre Corpo fall?
We lack enough history to give a specific floor for Sabre Corpo. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Sabre Corpo do?
Sabre laver software og teknologi til rejsebranchen globalt. De driver i bund og grund en stor B2B-markedsplads, hvor de forbinder flyselskaber, hoteller og biludlejningsfirmaer med rejsebureauer og virksomheder. Sabre tjener penge på at facilitere de her transaktioner.
En st... The company belongs to the Teknologi sector, more specifically the Software - Infrastructure industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Sabre Corpo as an investment.
Did Sabre Corpo raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Sabre Corpo. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Sabre Corpo making money or losing money?
Yes, Sabre Corpo is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 17.6% — which is solid. The operating margin (profit before interest and taxes) is 15.3%. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Sabre Corpo go bankrupt?
The bankruptcy risk of Sabre Corpo is rated as elevated. Altman Z2 (a model for assessing financial distress) is -3.25 — that places the company in the weak zone. This is a probability based on the numbers, not a verdict — bankruptcy is not imminent. But the balance sheet is measurably weaker than average, so watch the debt, liquidity and possible capital raises. The Piotroski score (financial health 0-9, higher is better) is 6 — which is average. Debt relative to equity is 1,000% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Sabre Corpo have a lot of debt?
Yes, Sabre Corpo has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 1,000%. For the teknologi sector, anything above 150% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can Sabre Corpo service its debt? Could struggle to service its debt — the interest coverage ratio (how many times earnings can cover interest payments) is -1.0x, and net debt equals 8.7 years of earnings (EBITDA).
